BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Jairam R, Perrouin-Verbe M, Elneil S. Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder. Neurourol Urodyn 2018;37:S17-22. [PMID: 29336058 DOI: 10.1002/nau.23476] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Coolen RL, Groen J, Blok B. Electrical stimulation in the treatment of bladder dysfunction: technology update. Med Devices (Auckl) 2019;12:337-45. [PMID: 31572023 DOI: 10.2147/MDER.S179898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kitney D, Crook J, Chakrabarty B, Kanai A, Vahabi B, Lovick T, Fry C. The Frequency-Dependence of Pre- and Postganglionic Nerve Stimulation of Pig and Rat Bladder. Int Neurourol J 2021;25:210-8. [PMID: 34610714 DOI: 10.5213/inj.2142002.001] [Reference Citation Analysis]
3 Lehur PA, Sørensen M, Dudding TC, Knowles CH, de Wachter S, Engelberg S, Matzel KE; European SNM Expert Group. Programming Algorithms for Sacral Neuromodulation: Clinical Practice and Evidence-Recommendations for Day-to-Day Practice. Neuromodulation 2020;23:1121-9. [PMID: 32153080 DOI: 10.1111/ner.13117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Poole RL, Dale M, Morgan H, Oladapo T, Brookfield R, Morris R. Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance. Appl Health Econ Health Policy 2021. [PMID: 34964090 DOI: 10.1007/s40258-021-00701-0] [Reference Citation Analysis]
5 Tilborghs S, De Wachter S. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects. Expert Review of Medical Devices. [DOI: 10.1080/17434440.2022.2032655] [Reference Citation Analysis]
6 Karrer-Warzinek E, Abt D, Kim OC, Schmid HP, Engeler DS, Müllhaupt G. Safety of Magnetic Resonance Imaging in patients under Sacral Neuromodulation with an InterStim Neuromodulator. Urology 2021;154:115-9. [PMID: 33774042 DOI: 10.1016/j.urology.2021.03.013] [Reference Citation Analysis]
7 Albabtain M, Chughtai B, Cho A, Elterman D. Review of the rechargeable sacral neuromodulation system to treat refractory overactive bladder. Ther Deliv 2021;12:353-62. [PMID: 33821666 DOI: 10.4155/tde-2021-0007] [Reference Citation Analysis]
8 Groenendijk IM, Groen J, Scheepe JR, Blok BFM. Acute effect of sacral neuromodulation for treatment of detrusor overactivity on urodynamic parameters. Neurourol Urodyn 2020;39:695-701. [PMID: 31804759 DOI: 10.1002/nau.24252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Dudding TC, Lehur PA, Sørensen M, Engelberg S, Bertapelle MP, Chartier-Kastler E, Everaert K, Van Kerrebroeck P, Knowles CH, Lundby L, Matzel KE, Muñoz-Duyos A, Rydningen MB, de Wachter S. Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice. Neuromodulation 2021. [PMID: 34264542 DOI: 10.1111/ner.13494] [Reference Citation Analysis]